documents: FDA-2019-D-4656-0017

Regulatory documents from Regulations.gov including rules, proposed rules, notices, and supporting materials.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id agency_id docket_id title document_type subtype posted_date posted_year posted_month comment_start_date comment_end_date last_modified fr_doc_num open_for_comment withdrawn object_id
FDA-2019-D-4656-0017 FDA FDA-2019-D-4656 Interstitial Cystitis/Bladder Pain Syndrome: Establishing Drug Development Programs for Treatment; Revised Draft Guidance for Industry; Availability Notice Notice of Availability 2023-06-05T04:00:00Z 2023 6 2023-06-05T04:00:00Z   2023-06-05T15:40:29Z 2023-11899 0 0 0900006485abbf3a

Links from other tables